NCT02834013 2026-06-03Nivolumab and Ipilimumab in Treating Patients With Rare TumorsNational Cancer Institute (NCI)Phase 2 Active not recruiting798 enrolled
NCT03833700 2026-02-27A Study of E7386 in Participants With Advanced Solid Tumor Including Colorectal Cancer (CRC)Eisai Inc.Phase 1 Active not recruiting70 enrolled